These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15125612)

  • 1. Second allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia: case report and literature review.
    Chang YH; Jou ST; Lin DT; Lu MY; Lin KH
    J Pediatr Hematol Oncol; 2004 Mar; 26(3):190-3. PubMed ID: 15125612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three consecutive related bone marrow transplants for juvenile myelomonocytic leukaemia.
    Faraci M; Micalizzi C; Lanino E; Scuderi F; Morreale G; Dini G; Cappelli B; Dallorso S
    Pediatr Transplant; 2005 Dec; 9(6):797-800. PubMed ID: 16269054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature.
    Matthes-Martin S; Mann G; Peters C; Lion T; Fritsch G; Haas OA; Pötschger U; Gadner H
    Bone Marrow Transplant; 2000 Aug; 26(4):377-82. PubMed ID: 10982283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
    Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
    Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.
    Patel SA; Coulter DW; Grovas AC; Gordon BG; Harper JL; Warkentin PI; Wisecarver JL; Sanger WG; Coccia PF
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):491-4. PubMed ID: 24322499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
    Yoshimi A; Bader P; Matthes-Martin S; Starý J; Sedlacek P; Duffner U; Klingebiel T; Dilloo D; Holter W; Zintl F; Kremens B; Sykora KW; Urban C; Hasle H; Korthof E; Révész T; Fischer A; Nöllke P; Locatelli F; Niemeyer CM;
    Leukemia; 2005 Jun; 19(6):971-7. PubMed ID: 15800672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful hematopoietic stem cell transplantation from an HLA-mismatched parent for engraftment failure after unrelated cord blood transplantation in patients with juvenile myelomonocytic leukemia: Report of two cases.
    Akahane K; Watanabe A; Furuichi Y; Somazu S; Oshiro H; Goi K; Sakashita K; Muramatsu H; Hama A; Takahashi Y; Koike K; Kojima S; Sugita K; Inukai T
    Pediatr Transplant; 2019 May; 23(3):e13378. PubMed ID: 30786117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.
    Locatelli F; Nöllke P; Zecca M; Korthof E; Lanino E; Peters C; Pession A; Kabisch H; Uderzo C; Bonfim CS; Bader P; Dilloo D; Stary J; Fischer A; Révész T; Führer M; Hasle H; Trebo M; van den Heuvel-Eibrink MM; Fenu S; Strahm B; Giorgiani G; Bonora MR; Duffner U; Niemeyer CM; ;
    Blood; 2005 Jan; 105(1):410-9. PubMed ID: 15353481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
    Stieglitz E; Ward AF; Gerbing RB; Alonzo TA; Arceci RJ; Liu YL; Emanuel PD; Widemann BC; Cheng JW; Jayaprakash N; Balis FM; Castleberry RP; Bunin NJ; Loh ML; Cooper TM
    Pediatr Blood Cancer; 2015 Apr; 62(4):629-36. PubMed ID: 25704135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.
    Yoshimi A; Kojima S; Hirano N
    Paediatr Drugs; 2010; 12(1):11-21. PubMed ID: 20034338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion.
    Worth A; Rao K; Webb D; Chessells J; Passmore J; Veys P
    Blood; 2003 Mar; 101(5):1713-4. PubMed ID: 12393482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile myelomonocytic leukemia.
    Satwani P; Kahn J; Dvorak CC
    Pediatr Clin North Am; 2015 Feb; 62(1):95-106. PubMed ID: 25435114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating juvenile myelomonocytic leukemia from chronic myeloid leukemia in childhood.
    Chang YH; Jou ST; Lin DT; Lu MY; Lin KH
    J Pediatr Hematol Oncol; 2004 Apr; 26(4):236-42. PubMed ID: 15087951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Study on Treatment of Juvenile Myelomonocytic Leukemia with Haploidentical-Hematopoietic Stem Cell Transplantation].
    Ding L; Zhu H; Han DM; Wang ZD; Zheng XL; Dong L; Yan HM; Liu J; Zhu L; Xue M; Guo ZK; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1524-1527. PubMed ID: 29070137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Inagaki J; Fukano R; Nishikawa T; Nakashima K; Sawa D; Ito N; Okamura J
    Pediatr Blood Cancer; 2013 Jan; 60(1):116-20. PubMed ID: 22847790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML.
    Pulsipher MA; Adams RH; Asch J; Petersen FB
    Bone Marrow Transplant; 2004 Jan; 33(1):113-5. PubMed ID: 14704663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous control of third-degree graft-versus-host disease and prevention of recurrence of juvenile myelomonocytic leukemia (JMML) with 6-mercaptopurine following fulminant JMML relapse early after KIR-mismatched bone marrow transplantation.
    Stachel DK; Leipold A; Kuhlen M; Gravou-Apostolatou C; Hirv K; Bader P; Niemeyer CM; Beck JD; Holter W
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):672-4. PubMed ID: 16344675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Flotho C; Sommer S; Lübbert M
    Semin Cancer Biol; 2018 Aug; 51():68-79. PubMed ID: 29129488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group.
    Manabe A; Okamura J; Yumura-Yagi K; Akiyama Y; Sako M; Uchiyama H; Kojima S; Koike K; Saito T; Nakahata T;
    Leukemia; 2002 Apr; 16(4):645-9. PubMed ID: 11960345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.